Trandolapril; verapamil hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for trandolapril; verapamil hydrochloride and what is the scope of freedom to operate?
Trandolapril; verapamil hydrochloride
is the generic ingredient in two branded drugs marketed by Abbvie and Glenmark Pharms Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for trandolapril; verapamil hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 5 |
| DailyMed Link: | trandolapril; verapamil hydrochloride at DailyMed |
Recent Clinical Trials for trandolapril; verapamil hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Authority, Hong Kong | Phase 4 |
| Assaf-Harofeh Medical Center | |
| Mario Negri Institute for Pharmacological Research | Phase 3 |
See all trandolapril; verapamil hydrochloride clinical trials
Pharmacology for trandolapril; verapamil hydrochloride
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 1 mg/240 mg | 020591 | 1 | 2008-02-20 |
| TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 2 mg/180 mg and 2 mg/240 mg | 020591 | 1 | 2007-11-09 |
| TARKA | Extended-release Tablets | trandolapril; verapamil hydrochloride | 4 mg/ 240 mg | 020591 | 1 | 2007-07-24 |
US Patents and Regulatory Information for trandolapril; verapamil hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-002 | May 26, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-003 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-004 | Aug 30, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-002 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-004 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | TARKA | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020591-001 | Oct 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | trandolapril; verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079135-001 | May 26, 2010 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for trandolapril; verapamil hydrochloride
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
